# Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

> **NCT05654493** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 65 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** MicroPulse Transscleral Laser Therapy using revised P3 Delivery Device

## Key facts

- **NCT ID:** NCT05654493
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-18
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05654493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05654493, "Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05654493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*